We evaluated CNS damage in our patient cohort with MS using neurofilament light chain (NF-L), a promising intrathecal biomarker of neurodegeneration (28) and chitinase 3-like 1 (CHI3L1), a glycoprotein secreted by activated glia (29). This evidence concerns the gene CHI3L1 and myeloid sarcoma.